Corona Remedies acquires Wokadine brand from Dr Reddy’s
The acquisition is expected to create synergies with the company’s existing therapeutic portfolio while enhancing its positioning in hospital-driven segments
The acquisition is expected to create synergies with the company’s existing therapeutic portfolio while enhancing its positioning in hospital-driven segments
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
